129 related articles for article (PubMed ID: 8554791)
1. [Huntington disease: clinical and genetic study in a Spanish population].
Solís Pérez MP; Palau Martínez F; Burguera Hernández JA; Salazar Cifré A
Neurologia; 1995 Nov; 10(9):362-6. PubMed ID: 8554791
[TBL] [Abstract][Full Text] [Related]
2. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
[TBL] [Abstract][Full Text] [Related]
4. [Psychometric study in Huntington disease].
Pasquier F; Cabaret M; Petit H
Encephale; 1993; 19(4):303-11. PubMed ID: 8275917
[TBL] [Abstract][Full Text] [Related]
5. Unified Huntington's disease rating scale: clinical practice and a critical approach.
Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
[TBL] [Abstract][Full Text] [Related]
6. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
Fragassi NA; Stanzione M; Angelini R; Di Maio L
Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
[TBL] [Abstract][Full Text] [Related]
7. [The gene responsible for Huntington's disease in Spanish families: its diagnostic value and the relation between trinucleotide expansion and the clinical characteristics].
Benítez J; Fernández E; García Ruiz P; Robledo M; Ayuso C; García Yébenes J
Rev Clin Esp; 1994 Aug; 194(8):591-3. PubMed ID: 7938836
[TBL] [Abstract][Full Text] [Related]
8. What is the impact of education on Huntington's disease?
López-Sendón JL; Royuela A; Trigo P; Orth M; Lange H; Reilmann R; Keylock J; Rickards H; Piacentini S; Squitieri F; Landwehrmeyer B; Witjes-Ane MN; Jurgens CK; Roos RA; Abraira V; de Yébenes JG;
Mov Disord; 2011 Jul; 26(8):1489-95. PubMed ID: 21432905
[TBL] [Abstract][Full Text] [Related]
9. Predictors of neuropathological severity in 100 patients with Huntington's disease.
Rosenblatt A; Abbott MH; Gourley LM; Troncoso JC; Margolis RL; Brandt J; Ross CA
Ann Neurol; 2003 Oct; 54(4):488-93. PubMed ID: 14520661
[TBL] [Abstract][Full Text] [Related]
10. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease.
Finke K; Bublak P; Dose M; Müller HJ; Schneider WX
Brain; 2006 May; 129(Pt 5):1137-51. PubMed ID: 16504973
[TBL] [Abstract][Full Text] [Related]
11. Assessment of simple movements reflects impairment in Huntington's disease.
Saft C; Andrich J; Meisel NM; Przuntek H; Müller T
Mov Disord; 2006 Aug; 21(8):1208-12. PubMed ID: 16700032
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of trinucleotide repeat expansion as a new mechanism of mutation in Huntington's chorea: theoretical and applied aspects].
Illarioshkin SN; Ivanova-Smolenskaia IA; Markova ED; Nikol'skaia NN; Chabrashvili TZ; Insarova NG
Genetika; 1996 Jan; 32(1):103-9. PubMed ID: 8647411
[TBL] [Abstract][Full Text] [Related]
13. [Cognitive assessment of asymptomatic Huntington's disease carriers].
Gómez-Tortosa E; del Barrio Alba A; Sánchez Pernaute R; Benítez J; Barroso A; García Yébenes J
Neurologia; 1997; 12(6):226-31. PubMed ID: 9303588
[TBL] [Abstract][Full Text] [Related]
14. Effect of CAG repeat length on psychiatric disorders in Huntington's disease.
Vassos E; Panas M; Kladi A; Vassilopoulos D
J Psychiatr Res; 2008 Jun; 42(7):544-9. PubMed ID: 17610899
[TBL] [Abstract][Full Text] [Related]
15. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
Robins Wahlin TB; Lundin A; Dear K
Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
[TBL] [Abstract][Full Text] [Related]
16. Juvenile-onset huntington disease: a matter of perspective.
Biglan K; Shoulson I
Arch Neurol; 2007 Jun; 64(6):783-4. PubMed ID: 17562925
[No Abstract] [Full Text] [Related]
17. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
[TBL] [Abstract][Full Text] [Related]
18. Factors contributing to institutionalization in patients with Huntington's disease.
Rosenblatt A; Kumar BV; Margolis RL; Welsh CS; Ross CA
Mov Disord; 2011 Aug; 26(9):1711-6. PubMed ID: 21538527
[TBL] [Abstract][Full Text] [Related]
19. Advances in Huntington's disease diagnostics: development of a standard reference material.
Levin BC; Richie KL; Jakupciak JP
Expert Rev Mol Diagn; 2006 Jul; 6(4):587-96. PubMed ID: 16824032
[TBL] [Abstract][Full Text] [Related]
20. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
